BioArctic AB (publ) (LON:0RV2)

BioArctic AB Statistics

Total Valuation

BioArctic AB has a market cap or net worth of GBP 2.22 billion. The enterprise value is 2.08 billion.

Market Cap	2.22B
Enterprise Value	2.08B

Important Dates

The next estimated earnings date is Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	74.24M
Shares Outstanding	n/a
Shares Change (YoY)	+0.60%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	30.55%
Owned by Institutions (%)	46.50%
Float	55.80M

Valuation Ratios

The trailing PE ratio is 28.19 and the forward PE ratio is 66.99.

PE Ratio	28.19
Forward PE	66.99
PS Ratio	14.70
PB Ratio	14.31
P/TBV Ratio	14.31
P/FCF Ratio	26.49
P/OCF Ratio	25.84
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.81, with an EV/FCF ratio of 24.73.

EV / Earnings	26.31
EV / Sales	13.42
EV / EBITDA	19.81
EV / EBIT	20.02
EV / FCF	24.73

Financial Position

The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.02.

Current Ratio	4.18
Quick Ratio	3.14
Debt / Equity	0.02
Debt / EBITDA	0.04
Debt / FCF	0.04
Interest Coverage	40.41

Financial Efficiency

Return on equity (ROE) is 69.23% and return on invested capital (ROIC) is 53.68%.

Return on Equity (ROE)	69.23%
Return on Assets (ROA)	43.46%
Return on Invested Capital (ROIC)	53.68%
Return on Capital Employed (ROCE)	64.18%
Revenue Per Employee	1.24M
Profits Per Employee	646,939
Employee Count	107
Asset Turnover	1.04
Inventory Turnover	n/a

Taxes

In the past 12 months, BioArctic AB has paid 13.65 million in taxes.

Income Tax	13.65M
Effective Tax Rate	14.75%

Stock Price Statistics

The stock price has increased by +58.33% in the last 52 weeks. The beta is -0.92, so BioArctic AB's price volatility has been lower than the market average.

Beta (5Y)	-0.92
52-Week Price Change	+58.33%
50-Day Moving Average	298.01
200-Day Moving Average	238.87
Relative Strength Index (RSI)	52.50
Average Volume (20 Days)	6,101

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioArctic AB had revenue of GBP 151.29 million and earned 78.93 million in profits. Earnings per share was 0.89.

Revenue	151.29M
Gross Profit	146.87M
Operating Income	101.40M
Pretax Income	92.58M
Net Income	78.93M
EBITDA	n/a
EBIT	101.40M
Earnings Per Share (EPS)	0.89

Balance Sheet

The company has 148.58 million in cash and 3.68 million in debt, giving a net cash position of 144.91 million.

Cash & Cash Equivalents	148.58M
Total Debt	3.68M
Net Cash	144.91M
Net Cash Per Share	n/a
Equity (Book Value)	155.48M
Book Value Per Share	1.76
Working Capital	150.65M

Cash Flow

In the last 12 months, operating cash flow was 86.09 million and capital expenditures -2.10 million, giving a free cash flow of 83.98 million.

Operating Cash Flow	86.09M
Capital Expenditures	-2.10M
Free Cash Flow	83.98M
FCF Per Share	n/a

Margins

Gross margin is 97.08%, with operating and profit margins of 67.02% and 52.17%.

Gross Margin	97.08%
Operating Margin	67.02%
Pretax Margin	61.19%
Profit Margin	52.17%
EBITDA Margin	n/a
EBIT Margin	67.02%
FCF Margin	55.51%

Dividends & Yields

BioArctic AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.60%
Shareholder Yield	-0.60%
Earnings Yield	3.55%
FCF Yield	3.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6